Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, Querétaro, México.
Department of Medicine and Neurobiology, Center for Translational Neuroscience, Duke University Medical Center, Durham, North Carolina, United States of America.
PLoS One. 2019 May 2;14(5):e0212158. doi: 10.1371/journal.pone.0212158. eCollection 2019.
A better understanding of the molecular and cellular mechanisms involved in retinal hydro-mineral homeostasis imbalance during diabetic macular edema (DME) is needed to gain insights into retinal (patho-)physiology that will help elaborate innovative therapies with lower health care costs. Transient receptor potential cation channel subfamily vanilloid member 4 (TRPV4) plays an intricate role in homeostatic processes that needs to be deciphered in normal and diabetic retina. Based on previous findings showing that TRPV4 antagonists resolve blood-retina barrier (BRB) breakdown in diabetic rats, we evaluated whether TRPV4 channel inhibition prevents and reverts retinal edema in streptozotocin(STZ)-induced diabetic mice. We assessed retinal edema using common metrics, including retinal morphology/thickness (histology) and BRB integrity (albumin-associated tracer), and also by quantifying water mobility through apparent diffusion coefficient (ADC) measures. ADC was measured by diffusion-weighted magnetic resonance imaging (DW-MRI), acquired ex vivo at 4 weeks after STZ injection in diabetes and control groups. DWI images were also used to assess retinal thickness. TRPV4 was genetically ablated or pharmacologically inhibited as follows: left eyes were used as vehicle control and right eyes were intravitreally injected with TRPV4-selective antagonist GSK2193874, 24 h before the end of the 4 weeks of diabetes. Histological data show that retinal thickness was similar in nondiabetic and diabetic wt groups but increased in diabetic Trpv4-/- mice. In contrast, DWI shows retinal thinning in diabetic wt mice that was absent in diabetic Trpv4-/- mice. Disorganized outer nuclear layer was observed in diabetic wt but not in diabetic Trpv4-/- retinas. We further demonstrate increased water diffusion, increased distances between photoreceptor nuclei, reduced nuclear area in all nuclear layers, and BRB hyperpermeability, in diabetic wt mice, effects that were absent in diabetic Trpv4-/- mice. Retinas of diabetic mice treated with PBS showed increased water diffusion that was not normalized by GSK2193874. ADC maps in nondiabetic Trpv4-/- mouse retinas showed restricted diffusion. Our data provide evidence that water diffusion is increased in diabetic mouse retinas and that TRPV4 function contributes to retinal hydro-mineral homeostasis and structure under control conditions, and to the development of BRB breakdown and increased water diffusion in the retina under diabetes conditions. A single intravitreous injection of TRPV4 antagonist is however not sufficient to revert these alterations in diabetic mouse retinas.
需要更好地了解糖尿病性黄斑水肿 (DME) 期间视网膜水盐稳态失衡涉及的分子和细胞机制,以便深入了解视网膜的(病理)生理学,从而有助于制定具有更低医疗成本的创新疗法。瞬时受体电位阳离子通道香草素亚家族成员 4(TRPV4)在维持生理平衡的过程中发挥着复杂的作用,需要在正常和糖尿病视网膜中对其进行破译。基于先前的研究结果表明,TRPV4 拮抗剂可解决糖尿病大鼠的血视网膜屏障 (BRB) 破裂,我们评估了 TRPV4 通道抑制是否可预防和逆转链脲佐菌素 (STZ) 诱导的糖尿病小鼠的视网膜水肿。我们使用包括视网膜形态/厚度(组织学)和 BRB 完整性(白蛋白相关示踪剂)在内的常用指标评估视网膜水肿,还通过表观扩散系数 (ADC) 测量来量化水的流动性。ADC 通过扩散加权磁共振成像 (DW-MRI) 进行测量,在 STZ 注射后 4 周在糖尿病和对照组中离体采集。DWI 图像也用于评估视网膜厚度。通过以下方式对 TRPV4 进行基因缺失或药物抑制:左眼用作载体对照,右眼在 4 周糖尿病结束前 24 小时通过玻璃体内注射 TRPV4 选择性拮抗剂 GSK2193874。组织学数据表明,非糖尿病和糖尿病 wt 组的视网膜厚度相似,但糖尿病 Trpv4-/- 小鼠的视网膜厚度增加。相比之下,DWI 显示糖尿病 wt 小鼠的视网膜变薄,而糖尿病 Trpv4-/- 小鼠的视网膜则没有变薄。在外核层观察到紊乱,而在糖尿病 Trpv4-/- 视网膜中则没有。我们进一步证明,在糖尿病 wt 小鼠中,水扩散增加,光感受器核之间的距离增加,所有核层的核面积减少,以及 BRB 通透性增加,而在糖尿病 Trpv4-/- 小鼠中则没有这些作用。用 PBS 处理的糖尿病小鼠的视网膜显示水扩散增加,但 GSK2193874 不能使其恢复正常。非糖尿病 Trpv4-/- 小鼠视网膜的 ADC 图显示限制扩散。我们的数据表明,糖尿病小鼠的视网膜水扩散增加,TRPV4 功能有助于在对照条件下维持视网膜的水盐平衡和结构,并有助于在糖尿病条件下发生 BRB 破裂和增加视网膜水扩散。然而,玻璃体内单次注射 TRPV4 拮抗剂不足以逆转糖尿病小鼠视网膜的这些改变。